Advanced Materials Aerospace & defense Agriculture Automation & Process Control Automotive & Transportation Banking & Financial Services Biotechnology Building & Construction Chemicals Cloud Computing Communications Devices and Infrastructure Consumer Goods Country Reports Cyber Security Data Center & Networking Energy Energy Utilities Food & Beverage Global Reports Healthcare Industrial Goods Industry Updates Information and Communications Technology IoT, Bigdata & Digitalization IT & Telecom Medical Devices Mining, Minerals and Metals Networking and Communications Next-Generation Networking Technologies Oil & Gas Outsourcing Services Packaging Pharmaceuticals Regional Reports Semiconductor & Electronics Software & Solutions Technology & Media Travel & Tourism
-
H2-Receptor Antagonists Market
The H2-receptor antagonists market was valued at USD 7.92 billion in 2024 and is projected to reach USD 9.58 billion by 2032, reflecting a CAGR of 2.41% over the forecast period.
-
Alpha Emitters Market
The global Alpha Emitters Market was valued at USD 1,827.5 million in 2024 and is anticipated to reach USD 9,605.29 million by 2032, registering a CAGR of 23.05% during the forecast period (2025–2032).
-
Antihistamines Market
Antihistamines Market size was valued USD 541.69 million in 2024 and is anticipated to reach USD 995.23 million by 2032, at a CAGR of 7.9% during the forecast period.
-
Alzheimer’s Therapeutic Market
Alzheimer’s Therapeutic Market size was valued at USD 5219.5 million in 2024 and is anticipated to reach USD 10024.59 million by 2032, at a CAGR of 8.5% during the forecast period.
-
Neurological Diseases Treatment Market
Neurological Diseases Treatment Market was valued at USD 82.7 billion in 2024 and is anticipated to reach USD 115.73 billion by 2032, growing at a CAGR of 4.29 % during the forecast period.
-
Microbiome Therapeutics Market
The Microbiome Therapeutics Market was valued at USD 197.63 million in 2024 and is projected to reach USD 816.1 million by 2032, expanding at a CAGR of 19.4% during the forecast period.
-
Learning Disability Treatment Market
Learning Disability Treatment Market was valued at USD 10.5 billion in 2024 and is anticipated to reach USD 18.04 billion by 2032, growing at a CAGR of 7 % during the forecast period.
-
Listeria Monocytogenes Infections Treatment Market
The global Listeria monocytogenes infections treatment market was valued at USD 4,738.86 million in 2024 and is anticipated to reach USD 6,948.29 million by 2032, expanding at a CAGR of 4.9% during the forecast period (2025–2032).
-
Coenzyme Q10 (Ubiquinol) Market
The global Coenzyme Q10 (Ubiquinol) market was valued at USD 1,897.5 million in 2024 and is projected to reach USD 3,070.28 million by 2032, expanding at a CAGR of 6.2% during the forecast period (2025–2032).
-
Plasma Protease C1 Inhibitor Market
The Plasma Protease C1 Inhibitor market was valued at USD 1,787.6 million in 2024 and is projected to reach USD 3,694.74 million by 2032, registering a CAGR of 9.5% during the forecast period.
